SAROJA

Saroja Pharma Industries India Share Price

₹55.00
+ 2.15 (4.07%)
05 November, 2024 09:19 BSE: NSE: SAROJA ISIN: INE0PCL01011

Start SIP in Saroja Pharma Industries India

Start SIP

Saroja Pharma Industries India Performance

Day Range

  • Low 55
  • High 56
₹ 55

52 Week Range

  • Low 33
  • High 71
₹ 55
  • Open Price56
  • Previous Close53
  • Volume3200

Saroja Pharma Industries India Chart

  • Over 1 Month -4.1%
  • Over 3 Month + 17.02%
  • Over 6 Month + 17.9%
  • Over 1 Year -12%

Saroja Pharma Industries India Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr 22
Price to Book Ratio 1.5
EPS 2.2
Dividend 0
Relative Strength Index 45.64
Money Flow Index 34.24
MACD Signal 0.77
Average True Range 1.95

Saroja Pharma Industries India Investment Rating

  • Master Rating:
  • Saroja Pharma Industries India Ltd has an operating revenue of Rs. 183.16 Cr. on a trailing 12-month basis. An annual revenue de-growth of -19% needs improvement, Pre-tax margin of 3% needs improvement, ROE of 5% is fair but needs improvement. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 51 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 57 indicates it belongs to a fair industry group of Medical-Supplies and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

EPS Strength

N/A

Price Strength

Buyer Demand

Group Rank

Saroja Pharma Industries India Financials
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 4150
Operating Expenses Annual Cr 3847
Operating Profit Annual in Cr 33
Depreciation Cr 00
Interest Annual Cr 11
Tax Annual Cr 00
Net Profit Annual Cr 11
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 12
Cash from Investing Activity Annual Cr -5-5
Cash from Financing Annual Activity Cr 43
Net Cash Flow Annual Cr 00
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 155
Fixed Assets Annual Cr 94
Total Non Current Assets Annual Cr 95
Total Current Assets Annual Cr 1816
Total Assets Annual Cr 2721
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 3617
ROE Annual % 621
ROCE Annual % 1536
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 76
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Saroja Pharma Industries India Technicals

EMA & SMA

Current Price
₹55.00
+ 2.15 (4.07%)
pointer
  • Bullish Moving Average
  • ___
  • 8
  • Bearish Moving Average
  • ___
  • 8
  • 20 Day
  • ₹57.12
  • 50 Day
  • ₹54.80
  • 100 Day
  • ₹52.39
  • 200 Day
  • ₹52.27
  • 20 Day
  • ₹57.92
  • 50 Day
  • ₹54.73
  • 100 Day
  • ₹48.96
  • 200 Day
  • ₹50.63

Saroja Pharma Industries India Resistance and Support

PIVOT
₹55.34
Resistance
First Resistance 55.67
Second Resistance 56.33
Third Resistance 56.67
RSI 45.64
MFI 34.24
MACD Single Line 0.77
MACD -0.15
Support
First Support 54.67
Second Support 54.33
Third Supoort 53.67

Saroja Pharma Industries India Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,200 320,000 100
Week 4,800 480,000 100
1 Month
6 Month 6,146 466,054 75.83

Saroja Pharma Industries India Result Highlights

Saroja Pharma Industries India Synopsis

NSE-Medical-Supplies

Saroja Pharma Indust belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 50.19 Cr. and Equity Capital is Rs. 2.94 Cr. for the Year ended 31/03/2023. Saroja Pharma Industries India Ltd. is a Public Limited Listed company incorporated on 14/01/2019 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U24110MH2019PLC319508 and registration number is 319508.
Market Cap 22
Sales 41
Shares in Float 0.11
No of funds
Yield
Book Value 1.51
U/D Vol ratio 3.3
LTDebt / Equity 18
Alpha -0.07
Beta 0.78

Saroja Pharma Industries India Shareholding Pattern

Owner NameMar-24
Promoters 73.02%
Individual Investors 24.08%
Others 2.9%

Saroja Pharma Industries India Management

Name Designation
Mr. Biju Gopinathan Nair Chairman & Managing Director
Mr. Manish Dasharath Kamble Whole Time Director
Mr. Pulinattu Nandakumar Non Executive Director
Mr. Abhishek Agrawal Independent Director
Ms. Pinky Kataruka Independent Director
Ms. Sonal Jain Independent Director

Saroja Pharma Industries India Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Saroja Pharma Industries India Corporate Action

Date Purpose Remarks
2024-05-29 Audited Results

Saroja Pharma Industries India FAQs

What is Share Price of Saroja Pharma Industries India ?

Saroja Pharma Industries India share price is ₹55 As on 05 November, 2024 | 09:05

What is the Market Cap of Saroja Pharma Industries India ?

The Market Cap of Saroja Pharma Industries India is ₹22.1 Cr As on 05 November, 2024 | 09:05

What is the P/E ratio of Saroja Pharma Industries India ?

The P/E ratio of Saroja Pharma Industries India is As on 05 November, 2024 | 09:05

What is the PB ratio of Saroja Pharma Industries India ?

The PB ratio of Saroja Pharma Industries India is 1.5 As on 05 November, 2024 | 09:05

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23